Bone Marrow TransplantationBone MarrowTransplantation, AutologousBone Marrow CellsTransplantation, HomologousBone Marrow PurgingBone and BonesWhole-Body IrradiationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideHematopoietic Stem Cell TransplantationBone Marrow DiseasesHematopoietic Stem CellsTransplantation ConditioningLymphoma, Non-HodgkinCarmustineLeukemiaBusulfanAnemia, AplasticGraft SurvivalHematopoiesisRemission InductionMelphalanLeukemia, Myeloid, AcuteBone Marrow ExaminationTransplantation ChimeraAntineoplastic Combined Chemotherapy ProtocolsBone RemodelingColony-Forming Units AssayRecurrenceTreatment OutcomeBone Marrow NeoplasmsEtoposideTissue DonorsLiver TransplantationHodgkin DiseaseTransplantation, IsogeneicLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaTime FactorsHistocompatibility TestingCytarabineStem Cell TransplantationMice, Inbred C57BLHistocompatibilityBone DensityRadiation ChimeraSurvival AnalysisActuarial AnalysisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAcute DiseaseHepatic Veno-Occlusive DiseaseHematologic DiseasesMyelodysplastic SyndromesBone ResorptionKidney TransplantationLymphomaImmunosuppressive AgentsT-LymphocytesMultiple MyelomaGranulocyte Colony-Stimulating FactorCell DifferentiationFollow-Up StudiesBone TransplantationLeukocyte CountDrug EvaluationImmunosuppressionHematologic NeoplasmsThiotepaVincristineSurvival RateRetrospective StudiesDisease-Free SurvivalAntigens, CD34Cells, CulturedPodophyllotoxinGraft RejectionGranulocytesSalvage TherapyFlow CytometryBone NeoplasmsGraft vs Host ReactionLymphocyte DepletionTransplantation ImmunologyCell SeparationCyclosporineChimeraLeukocyte TransfusionPrognosisAntibodies, MonoclonalGranulocyte-Macrophage Colony-Stimulating FactorBlood Cell CountSevere Combined ImmunodeficiencyPlatelet CountHLA AntigensStromal CellsPancytopeniaSpleenBone Development